Takeda Pharmaceutical Company
Research Takeda Pharmaceutical Company (TAK) on Bullrun: market cap USD 58.00B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTAK
- ExchangeNYSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 58.00B
- Financial periodQ2 2026
- RevenueJPY 1.22T
- Net incomeJPY 113.20B
- Free cash flowJPY 127.60M
- Gross margin66.7%
Valuation Snapshot
latest market cap is USD 58.00B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 4.46T | JPY 112.93B | JPY 746.07B | 65.3% | n/a | JPY 654.94B | JPY 4.85T | JPY 7.64T |
| FY2024 | JPY 4.58T | JPY 208.07B | JPY 746.69B | 65.5% | 231.38 | JPY 494.13B | JPY 4.84T | JPY 7.42T |
| FY2023 | JPY 4.17T | JPY 178.22B | n/a | 67.5% | n/a | JPY 288.36B | JPY 4.66T | JPY 6.74T |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 58.00B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 49.24B | 65.0 | n/a | n/a |
| 2024 | 2024-12-31 | USD 41.98B | 30.8 | n/a | n/a |
| 2023 | 2023-12-29 | USD 44.78B | 32.4 | n/a | n/a |
| 2022 | 2022-12-30 | USD 48.50B | 29.4 | n/a | n/a |
| 2021 | 2021-12-31 | USD 42.46B | 10.6 | n/a | n/a |
About Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Takeda Pharmaceutical Company's market cap?
Takeda Pharmaceutical Company's market capitalization is USD 58.00B.
What does Takeda Pharmaceutical Company do?
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.